InsidersTradesSigma
Follow the Chosa Oncology AB stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Market capitalisation: €63.8m. The latest transaction was disclosed on 17 July 2026 (Purchase). Among the most active insiders: Peter Buhl. All data is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Chosa Oncology AB is a biotechnology company focused on developing innovative cancer treatments. It is listed on the XSTO exchange.